Author:
Rai Mridula,Ahlberg Alan W.,Marwell Julianna,Chaudhary Waseem,Savino John A.,Alter Eric L.,Henzlova Milena J.,Duvall W. Lane
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging
Reference30 articles.
1. http://www.fda.gov/Drugs/DrugSafety/ucm375654.htm
.
2. Hsi DH, Marreddy R, Moshiyakhov M, Luft U. Regadenoson induced acute ST-segment elevation myocardial infarction and multivessel coronary thrombosis. J Nucl Cardiol. 2013;20:481-4.
3. Shah S, Parra D, Rosenstein RS. Acute myocardial infarction during regadenoson myocardial perfusion imaging. Pharmacotherapy. 2013;33:e90–5.
4. http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm41872111111136.htm
.
5. Lette J, Tatum JL, Fraser S, Miller DD, Waters DD, Heller G, et al. Safety of dipyridamole testing in 73,806 patients: the multicenter dipyridamole safety study. J Nucl Cardiol. 1995;2:3–17.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献